title: Effect of hypoxanthine, antioxidants and allopurinol on cholinesterase activities in rats.
abstract: In the present study, we investigate the in vitro effect of hypoxanthine on acetylcholinesterase and butyrylcholinesterase activities in the hippocampus, striatum, cerebral cortex and serum of 15-, 30- and 60-day-old rats. Furthermore, we also evaluated the influence of antioxidants, namely α-tocopherol (trolox) and ascorbic acid, and allopurinol to investigate the possible participation of free radicals and uric acid in the effects elicited by hypoxanthine on these parameters. Acetylcholinesterase and butyrylcholinesterase activities were determined according to Ellman et al. (Biochem Pharmacol 7:88-95, 1961), with some modifications. Hypoxanthine (10.0 μM), when added to the incubation medium, enhanced acetylcholinesterase activity in the hippocampus and striatum of 15- and 30-day-old rats and reduced butyrylcholinesterase activity in the serum of 60-day-old rats. The administration of allopurinol and/or antioxidants partially prevented the alterations caused by hypoxanthine in acetylcholinesterase and butyrylcholinesterase activities in the cerebrum and serum of rats. Data indicate that hypoxanthine alters cholinesterase activities, probably through free radicals and uric acid production since the alterations were prevented by the administration of allopurinol and antioxidants. It is presumed that the cholinesterase system may be associated, at least in part, with the neuronal dysfunction observed in patients affected by Lesch-Nyhan disease. In addition, although extrapolation of findings from animal experiments to humans is difficult, it is conceivable that these vitamins and allopurinol might serve as an adjuvant therapy to avoid progression of brain damage in patients affected by this disease.
authors: Departamento de Medicina, Centro de Ciências da Saúde, Universidade Regional de Blumenau, Rua Antônio da Veiga, 140, Blumenau, SC, CEP 89012-900, Brazil.
authors: Morgahna Nathalie
authors: MN
authors: Wamser
authors: Eduardo Fernandes
authors: EF
authors: Leite
authors: Vinícius Vialle
authors: VV
authors: Ferreira
authors: Daniela
authors: D
authors: Delwing-de Lima
authors: José Geraldo Pereira
authors: JG
authors: da Cruz
authors: Angela T S
authors: AT
authors: Wyse
authors: Débora
authors: D
authors: Delwing-Dal Magro
mesh_terms: D000110:Acetylcholinesterase / Q000378:metabolism; D000493:Allopurinol / Q000494:pharmacology*; D000704:Analysis of Variance; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology; D002091:Butyrylcholinesterase / Q000378:metabolism; D002802:Cholinesterases / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005609:Free Radicals / Q000378:metabolism; D019271:Hypoxanthine / Q000134:cerebrospinal fluid / Q000494:pharmacology*; D007926:Lesch-Nyhan Syndrome / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D014527:Uric Acid / Q000378:metabolism; D024502:alpha-Tocopherol / Q000494:pharmacology
chemical_list: D000975:Antioxidants; D004791:Enzyme Inhibitors; D005609:Free Radicals; D014527:Uric Acid; D019271:Hypoxanthine; D000493:Allopurinol; D000110:Acetylcholinesterase; D002091:Butyrylcholinesterase; D002802:Cholinesterases; D024502:alpha-Tocopherol; D001205:Ascorbic Acid
references: Prog Neurobiol. 1993 Jul;41(1):31-91
references: 8321908
references: Arch Neurol. 1999 Mar;56(3):303-8
references: 10190820
references: Fed Proc. 1968 Jul-Aug;27(4):1075-7
references: 4298064
references: Neurosci Res. 2003 Jan;45(1):117-27
references: 12507730
references: Clin Chim Acta. 2005 Jun;356(1-2):35-57
references: 15936302
references: Brain Res. 2005 Apr 18;1041(2):198-204
references: 15829228
references: Brain Res Brain Res Rev. 2003 Mar;41(2-3):268-87
references: 12663083
references: Biochem Pharmacol. 1961 Jul;7:88-95
references: 13726518
references: Drugs Today (Barc). 2004 Aug;40(8):711-21
references: 15510242
references: Cell. 1981 Jul;25(1):67-82
references: 6895049
references: Am J Med. 1964 Apr;36:561-70
references: 14142409
references: Neurochem Res. 2007 Nov;32(11):1868-74
references: 17701348
references: Eur J Pharmacol. 1998 Apr 3;346(1):1-13
references: 9617746
references: Hum Genet. 1981;57(1):39-47
references: 7262868
references: Neurochem Int. 2004 Jan;44(1):45-52
references: 12963087
references: Exp Neurol. 1995 Aug;134(2):157-78
references: 7556536
references: Psychoneuroendocrinology. 1996 May;21(4):421-30
references: 8844880
references: Metab Brain Dis. 2007 Mar;22(1):1-11
references: 17226099
references: Nat Rev Neurosci. 2003 Feb;4(2):131-8
references: 12563284
references: Nihon Rinsho. 1996 Dec;54(12):3309-14
references: 8976111
references: Adv Clin Chem. 2004;38:151-216
references: 15521192
references: J Inherit Metab Dis. 1988;11(3):239-52
references: 3148065
references: Brain Dev. 2000 Sep;22 Suppl 1:S122-31
references: 10984673
references: Pharmacogenetics. 2003 Apr;13(4):231-9
references: 12668920
references: Anal Biochem. 1976 May 7;72:248-54
references: 942051
references: JAMA. 1967 Oct 16;202(3):175-7
references: 6072350
references: Clin Biochem. 2000 Mar;33(2):103-6
references: 10751587
references: J Neural Transm Suppl. 1995;45:27-34
references: 8748606
references: Neurochem Res. 2004 Feb;29(2):385-9
references: 15002734
references: Neurochem Res. 2002 Dec;27(12):1685-9
references: 12515323
references: Mov Disord. 2003 Aug;18(8):860-71
references: 12889075
references: Metab Brain Dis. 2007 Mar;22(1):67-76
references: 17221304
references: Orphanet J Rare Dis. 2007 Dec 08;2:48
references: 18067674
references: Lipids. 1990 Apr;25(4):199-210
references: 2345493
references: Brain Res. 2008 Nov 6;1239:198-206
references: 18775418
references: Contrib Nephrol. 2005;147:22-34
references: 15604603
references: Free Radic Biol Med. 1996;21(5):713-7
references: 8891675
references: Behav Brain Res. 1983 Jul;9(1):83-104
references: 6882520
references: Neuropsychologia. 2005;43(3):442-9
references: 15707619
references: Am J Med Genet. 2002 Mar 15;108(3):219-22
references: 11891689
references: J Korean Med Sci. 2004 Apr;19(2):209-13
references: 15082892
references: Metab Brain Dis. 2003 Mar;18(1):79-86
references: 12603084
references: N Engl J Med. 1981 Nov 5;305(19):1106-11
references: 6117011
references: Neuroscience. 2002;110(4):627-39
references: 11934471
references: Br J Pharmacol. 2008 Aug;154(8):1558-71
references: 18500366